Highwoods Prices $350 Million of 5.350% Notes Due 2033

(NYSE:HIW), RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE: HIW) (the “Company”) announced today that Highwoods Realty Limited Partnership, the operating partnership through which the Company conducts its operations, has priced a $350 million offering of 5.350% unsecured notes under its existing shelf registration statement. The notes are due January 15, […]

Par Pacific Holdings Reports Third Quarter 2025 Results

(NYSE:PARR), HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2025. Net Income of $262.6 million, or $5.16 per diluted share Adjusted Net Income of $302.6 million, or $5.95 per diluted share Adjusted EBITDA of

HP Inc. to Announce Fourth Quarter Fiscal 2025 Earnings on Nov 25, 2025

(NYSE:HPQ), PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the fourth fiscal quarter and fiscal year ended October 31, 2025 on Tuesday, Nov 25, 2025 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast

Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal

(NYSE:WSR), HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR), a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has received an unsolicited, non-binding proposal from MCB Real Estate to acquire all of the outstanding shares of the Company's common stock for cash consideration of

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 GlobeNewswire November 04, 2025 SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following

Macerich Reports Third Quarter 2025 Earnings Results

(NYSE:MAC), SANTA MONICA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its Third Quarter 2025 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com. As previously announced, management will hold a conference call at 2:00 p.m. Pacific Time (5:00 p.m.

Great Elm Capital Corp. Announces Third Quarter 2025 Financial Results

Great Elm Capital Corp. Announces Third Quarter 2025 Financial Results Company to Host Conference Call and Webcast at 8:30 AM ET on November 5, 2025 GlobeNewswire November 04, 2025 Board Maintains $0.37 Per Share Distribution and Announces $10 Million Share Repurchase Authorization GECC Strengthened its Balance Sheet Raising $27 Million of Equity and Refinancing Highest

AMD Reports Third Quarter 2025 Financial Results

AMD Reports Third Quarter 2025 Financial Results GlobeNewswire November 04, 2025 SANTA CLARA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — AMD (NASDAQ:AMD) today announced financial results for the third quarter of 2025. Third quarter revenue was a record $9.2 billion, gross margin was 52%, operating income was $1.3 billion, net income was $1.2 billion and

Navigator Gas Announces Preliminary Third Quarter 2025 Results (Unaudited)

Navigator Gas Announces Preliminary Third Quarter 2025 Results (Unaudited) GlobeNewswire November 04, 2025 LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Third Quarter Financial Highlights On November 4, 2025, the Board of Directors of Navigator Holdings Ltd., (NYSE: NVGS) (“Navigator Holdings”, “Navigator Gas”, “our”, “we”, “us” or the “Company”) approved a revision to the Company's existing

Anaptys Announces Participation in November Investor Conferences

Anaptys Announces Participation in November Investor Conferences GlobeNewswire November 04, 2025 SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled

Scroll to Top